Who owns PHIBRO ANIMAL HEALTH CORP (PAH)? Elite investor 13F holders
2 tracked elite investors reported holding PHIBRO ANIMAL HEALTH CORP as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | PHIBRO ANIMAL HEALTH CORP | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 15087700.00 USD | 480500.000000 | Shares | reduce | Original filing |
| D.E. Shaw | PHIBRO ANIMAL HEALTH CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 856058.00 USD | 27263.000000 | Shares | add | Original filing |
| Polen Capital Management | PHIBRO ANIMAL HEALTH CORP | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.